Foundations & Future Plans For Precision Medicine In The Treatment Of GAD
Generalized anxiety disorder (GAD) is a broad disorder marked by uncontrollable worry that affects daily life for at least six months. It is considered a chronic condition and is marked by feelings of restlessness, fatigue, tension, and irritability, as well as sleep disturbances and, in some cases, cognitive difficulty. GAD affects an estimated 2.7% of the adult population in the United States annually and has a lifetime prevalence of nearly 6%. While, GAD is believed to be controlled by more …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.